Hiv integrase inhibitors

Hydroxy (tetra- or hexa-)hydronaphthyridine dione compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I) wherein a, R,1?, R,2?, R,3?, R,4? and R,5? are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the preve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CAMERON MARK, HOERMER R. S, MANCHENO DANNY E, FOSTER BRUCE S, WAI JOHN S, ANGELAUD REMY, WILLIAMS PETER D, PAYNE LINDA S, ZHUANG LINGHANG, NEILSON LOU A, EGBERTSON MELISSA, HAN WEI, ASKIN DAVID, DOLLING ULF H, MORRISSETTE MATTHEW M, RUZEK ROWENA D, ISAACS RICHARD C, KIM BOYOUNG, PERLOW DEBRA S, PYE PHILIP J, OBLIGADO VANESSA E
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hydroxy (tetra- or hexa-)hydronaphthyridine dione compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I) wherein a, R,1?, R,2?, R,3?, R,4? and R,5? are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.